Brolin Robert E, LaMarca Lisa B, Kenler Hallis A, Cody Ronald P
Department of Surgery, St. Peter's University Hospital, New Brunswick, NJ 08903, USA.
J Gastrointest Surg. 2002 Mar-Apr;6(2):195-203; discussion 204-5. doi: 10.1016/s1091-255x(01)00022-1.
Weight loss in superobese patients has been problematic after conventional gastric restrictive operations including conventional Roux-en-Y gastric bypass (RYGB). The goal of the present study was to compare weight loss in patients with superobesity (body mass index > or =50 kg/m(2)) using a distal RYGB (D-RY) in which the Roux-en-Y anastomosis was performed 75 cm proximal to the ileocecal junction (N = 47) vs. patients who had Roux limbs of 150 cm (N = 152) and 50 to 75 cm (N = 99). All operations incorporated the same gastric restrictive parameters. Minimum follow-up was 3 years and ranged to 16 years. Weight loss and reduction in body mass index were significantly greater after D-RY vs. both RYGB-150 cm and short RYGB and in RYGB-150 cm vs. short RYGB through 5 years. Mean percentage of excess weight loss peaked at 64% after DRY, at 61% after RYGB-150 cm, and at 56% after short RYGB. Weight loss maintenance through 5 years was correlated with Roux limb length with D-RY greater than RYGB-150 cm greater than short RYGB. More than 95% of obesity-related comorbid conditions improved or resolved with weight loss. There was no difference in the early postoperative morbidity rates: 9% after D-RY; 8% after RYGB-150 cm; and 2% after short RYGB with one death (0.3%). All D-RY patients had at least one postoperative metabolic abnormality. Anemia was significantly more common after D-RY vs. the shorter RYGB with no difference in the incidence of metabolic sequelae between RYGB-150 cm and short RYGB. No operations were reversed or modified for nutritional complications. Two D-RY patients required total parenteral nutrition for protein malnutrition. These results show that Roux limb length is correlated with weight loss in superobese patients. However, the greater incidence of metabolic sequelae after D-RY vs. RYGB-150 cm calls into question its routine use in superobese patients undergoing bariatric surgery. We conclude that some degree of malabsorption should be incorporated into bariatric operations performed in superobese patients to achieve satisfactory long-term weight loss.
在包括传统Roux-en-Y胃旁路术(RYGB)在内的传统胃限制性手术后,超级肥胖患者的体重减轻一直存在问题。本研究的目的是比较超级肥胖患者(体重指数≥50kg/m²)采用远端RYGB(D-RY,Roux-en-Y吻合口在回盲部近端75cm处,N = 47)与Roux袢长150cm(N = 152)和50至75cm(N = 99)的患者的体重减轻情况。所有手术都采用相同的胃限制参数。最短随访时间为3年,最长为16年。在5年时间里,D-RY术后的体重减轻和体重指数降低显著大于RYGB-150cm组和短Roux袢RYGB组,且RYGB-150cm组大于短Roux袢RYGB组。D-RY术后多余体重减轻的平均百分比峰值为64%,RYGB-150cm组为61%,短Roux袢RYGB组为56%。5年的体重减轻维持情况与Roux袢长度相关,D-RY大于RYGB-150cm大于短Roux袢RYGB。超过95%的肥胖相关合并症随着体重减轻而改善或缓解。术后早期发病率无差异:D-RY术后为9%;RYGB-150cm术后为8%;短Roux袢RYGB术后为2%,有1例死亡(0.3%)。所有D-RY患者术后至少有一项代谢异常。与较短Roux袢RYGB相比,D-RY术后贫血明显更常见,RYGB-150cm和短Roux袢RYGB之间代谢后遗症的发生率无差异。没有手术因营养并发症而被逆转或修改。两名D-RY患者因蛋白质营养不良需要全胃肠外营养。这些结果表明,Roux袢长度与超级肥胖患者的体重减轻相关。然而,与RYGB-150cm相比,D-RY术后代谢后遗症的发生率更高,这使其在接受减肥手术的超级肥胖患者中的常规应用受到质疑。我们得出结论,在超级肥胖患者进行的减肥手术中应纳入一定程度的吸收不良,以实现令人满意的长期体重减轻。